newsfilter
← Latest News
PR Newswire·

Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc. (Nasdaq: VERV). Verve is a ...